Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Finerenone in Patients With Heart Failure With Reduced Ejection Fraction

NCT05974566 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.

NCT NCT05974566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05974566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Finerenone in Patients With Heart Failure With Reduced Ejection Fraction
Lead sponsor
Chongqing Medical University
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2023
Completion date
October 30, 2023
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetic nephropathies, heart failure with reduced ejection fraction